You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 2. Cardiovascular adverse effects of immunotherapy in cancer: insights and implications
- 3. Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics
- 4. Fusobacterium nucleatum promotes metastasis of breast cancer via the miR-21-3p/FOXO3 axis
- 5. A pan-cancer analysis of the prognostic and immunological roles of zinc finger protein 514 in human tumors
- 6. Singlera Genomics and Partners publish results from GUIDE prospective cohort study demonstrating blood-based early detection of gastrointestinal cancers using DNA methylation-based GutSeer assay
- 7. Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial
- 8. Development and validation of hybrid machine learning approach for predicting survival in patients with cervical cancer: a SEER-based population study
- 9. Human annexin A5 promotes glioma progression by targeting the MAPK/CD44 pathway
- 10. PreciseDx Secures $11M in New Funding
Last updated at 23:27 GMT
Hot News Makers
Health/Pharma Companies
-
1513443.33
-
18708.26
-
8077.12
-
6137.89
-
5693.94
-
5498.86
-
5298.93
-
4879.90
-
4855.72
-
4125.21
Drugs, Treatments, Trials
-
8428.63
-
5136.84
-
4075.94
-
2868.82
-
2786.80
-
1923.97
-
1576.40
-
1110.48
-
1070.84
-
1054.72
Last updated at 23:10 GMT
